The selection of bellwether trials will mark an important milestone in the Pradaxa bleeding litigation. We are pleased to see this proceeding moving forward.
New York, New York (PRWEB) November 11, 2013
Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) filed on behalf of individuals who suffered serious instances of internal bleeding, allegedly due to Pradaxa, continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to a Case Management Order issued on November 4th, the Court has established a protocol for the selection of bellwether cases in the Pradaxa bleeding litigation. Among other things, the Order directs the parties to each select up to three individual Pradaxa lawsuits as possible bellwether cases, and submit their selections to the Court on December 15th at 5:00 p.m. By January 23, 2014, the Court will select four of those cases for the litigation’s first bellwether trials. Those trials are scheduled to begin in August 2014. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
“The selection of bellwether trials will mark an important milestone in the Pradaxa bleeding litigation. We are pleased to see this proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding side effects.
According to court documents, at least 1,767 Pradaxa lawsuits are now pending in the litigation underway in the Southern District of Illinois. Plaintiffs allege that Boehringer Ingelheim failed to provide adequate warnings to doctors and patients regarding the lack of a readily available antidote to reverse Pradaxa bleeding.
In October, the Institute for Safe Medicine Practices (ISMP) reported that the U.S. Food & Drug Administration (FDA) had tallied more than 3,292 reports of adverse events and 582 deaths involving Pradaxa side effects in 2012, more than any other drug it tracked that year.* According to a recent Bloomberg.com report, regulators in several countries have issued Pradaxa side effect alerts, mostly due to its association with internal bleeding. Though the drug has been marketed as an improvement over warfarin, internal hemorrhaging caused by that decades-old blood thinner can be ended via the administration of vitamin K. However, there as yet exists no readily available antidote to reverse bleeding that can sometimes accompany Pradaxa use.**
Individuals allegedly injured by Pradaxa may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn More about possible Pradaxa side effects by visiting Bernstein Liebhard LLP’s website. For a free review of your potential Pradaxa lawsuit, please call 800-511-5092.
*ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP, October 17, 201
**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com